NCT06934057
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06934057
Title Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma (CABOLD)
Acronym CABOLD
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest - Angers NOT_YET_RECRUITING Angers 49055 France Details
Centre Georges François Leclerc NOT_YET_RECRUITING Dijon 21079 France Details
Centre Léon Bérard NOT_YET_RECRUITING Lyon 69373 France Details
Hôpital Tenon NOT_YET_RECRUITING Paris 75020 France Details
Institut Universitaire Du Cancer Toulouse- Oncopole Claudius Regaud NOT_YET_RECRUITING Toulouse 31059 France Details
CHU Tours - Hôpital Bretonneau NOT_YET_RECRUITING Tours 37044 France Details
Gustave Roussy RECRUITING Villejuif 94800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field